Novartis AG Equity-NMS: NVS

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$113.74
Open :	$112.4
Today's high :	$115.54
Today's low :	$112.34
52W low :	$92.7237
52W high :	$124.83
1Y :	2.75%
5Y :	45%
EPS(TTM): :	6.86
Shares O/S :	1.94 B
Market cap :	223.2 B

What is the share price of Novartis AG today?

Novartis AG (NVS) share price as of August 2, 2025, is $115.3. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Novartis AG?

Yes, Indian Investors can invest in the Novartis AG (NVS) Share by opening an international trading account with Angel One.

How can I purchase Novartis AG shares in India?

Purchasing Novartis AG (NVS) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Novartis AG (NVS) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Novartis AG?

Yes, you can purchase fractional shares of Novartis AG (NVS) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Novartis AG?

The market capitalization of Novartis AG on August 2, 2025, is $223.2 B.

In which sector Novartis AG belongs?

Novartis AG operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in Novartis AG stocks?

In order to invest in Novartis AG (NVS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.